source
- FDA's PDUFA VIII adds 'America First' incentives and speeds up drug reviewsThe Food and Drug Administration announced the next five‑year reauthorization of the Prescription Drug User Fee Act, known as PDUFA VIII. The agency said the new framework will introduce several po…
- Karyopharm faces default risk with only a month left to rescue cancer expansionKaryopharm Therapeutics, a commercial-stage cancer drugmaker, is confronting severe financial strain as its market capitalization is roughly one‑third of the revenue it expects to generate in 2026.…